Cytori Announces New U.S. Investigator Trial for Hip Osteonecrosis
Benzinga,
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) ("Cytori" or "the Company") today…
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ:CYTX) ("Cytori" or "the Company") today…
GlobeNewswire 2017-11-13 Updates on Other Selected Global Investigator Initiated Trials SAN DIEGO, Nov.
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or “the Company”) today…
SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq:CYTX) (“Cytori” or “the Company”) today…